The FDA gave de novo approval to Gauss Surgical's Triton Fluid Management System blood loss monitor. The approval is significant because the device uses an iPad camera and cloud analytics. The company intended to file a 510(k) but instead spent 15 months going through the de novo approval process because the FDA could not find a substantially equivalent device. Story